Wall Street firm calls for buying BP after years of underperformance

The case for buying BP is now being made by a leading Wall Street firm, a stance that complicates the prevailing view of the integrated oil giant as a laggard. For the last three to five years, BP has trailed its closest rivals, a performance gap that has defined its market position through two major energy crises. The new recommendation suggests the risk is no longer in the underperformance, but in missing the entry point for a beleaguered company.

The evidence for a turnaround The primary driver for this shift in sentiment is the simple arithmetic of relative value. BP has consistently lagged its peers over a significant multi-year horizon, a period that spans distinct phases of the energy market. The recommendation from the Wall Street firm is not based on a sudden change in operational output, but on the valuation disconnect created by this sustained underperformance. The read-through is that the market has punished the stock sufficiently to create an attractive setup for new capital.

The counterargument The strongest counterargument is that the past three to five years of lagging performance is not an anomaly but a signal of structural issues. If BP has failed to keep pace with its closest rivals through two energy crises, the risk is that the underlying business model remains less competitive than the market currently prices. The counterargument holds that the stock is cheap for a reason, and that the gap between BP and its peers is likely to persist rather than close. This view suggests that the recommendation is a value trap, where low price masks a lack of future growth potential.

On balance On balance, the decision to buy BP hinges on whether the market is over-penalizing the company for past failures. The Wall Street firm argues that the lag is now a feature of the opportunity, not a bug. The line to watch is whether the stock can finally match the performance of its rivals, validating the new bullish stance. Until that happens, the investment remains a bet on mean reversion rather than fundamental improvement.